Pfizer expects higher COVID-19 vaccine prices and yearly boosters, CFO says. And that means big sales long-term

Pfizer made headlines last month when its chief financial officer said the company would look to raise COVID-19 vaccine prices after the pandemic wanes. The company is doubling down on that stance, and it now believes annual vaccinations are "increasingly likely."

Add those two things together, and you get a hefty long-term revenue stream.